In breast cancer cells, prostaglandin E2 (PGE2), one of the final products of the cyclooxygenase-2 (COX-2) pathway, can induce ST3GAL1 expression in both ER-positive and ER-negative cell lines [18]. This evidence concerns the gene ST3GAL1 and breast carcinoma.